TrialBritish journal of cancer2013

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO.

I Ray-Coquard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.